Changsoo Paul Kang

Title: Changsoo Paul Kang: Innovator in Stuttering Research

Introduction

Changsoo Paul Kang is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of speech disorders, particularly in understanding and treating stuttering. His innovative work has led to the development of a patent that addresses the genetic factors associated with this condition.

Latest Patents

Changsoo Paul Kang holds a patent titled "Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering." This patent focuses on the allelic variants or mutations in three genes: GNPTAB, GNPTG, and NAGPA, which correlate with stuttering in humans. The patent also includes the encoded mutated polypeptides, related vectors, host cells, antibodies, and methods for diagnosing, prognosticating, and treating stuttering. He has 1 patent to his name.

Career Highlights

Throughout his career, Changsoo Paul Kang has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the Centre of Excellence in Molecular Biology at the University of Punjab. His work in these institutions has been pivotal in advancing research in molecular biology and genetics.

Collaborations

Changsoo has collaborated with esteemed colleagues such as Dennis Drayna and Sheikh Riazuddin. Their combined expertise has contributed to the understanding of genetic influences on speech disorders.

Conclusion

Changsoo Paul Kang's innovative research and patent in the field of stuttering highlight his commitment to improving the lives of individuals affected by this condition. His work continues to inspire advancements in diagnostic and therapeutic approaches.